A Randomized, Double-Blind, Placebo-Controlled Pilot Trial of KB001 in Mechanically-Ventilated Patients Colonized With Pseudomonas Aeruginosa
Phase of Trial: Phase I/II
Latest Information Update: 07 Aug 2017
At a glance
- Drugs KB 001 (Primary)
- Indications Pseudomonal infections; Respiratory tract infections
- Focus Adverse reactions
- Sponsors Humanigen
- 07 Aug 2017 According to Humanigen media release, KaloBios Pharmaceuticals changed its name to Humanigen.
- 25 Jun 2012 Results were published in the online version of Critical Care Medicine.
- 18 May 2010 Results reported at American Thoracic Society meeting according to a KaloBios media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History